---

---

meeting   tags : Pre-clinical   

save search

---

Corbus Pharmaceuticals Presents Results of Two Pre-Clinical Studies on its Anti-αVβ8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting
Published: 2023-11-02 (Crawled : 12:00) - globenewswire.com
CRBP | $36.53 -1.7% -1.91% 130K |

Health Technology

| 714.26% | O: 3.69% H: 4.07% C: -6.99%
crb-601 pre-clinical antibody pharmaceuticals meeting results

---

Cellectis Presents Pre-Clinical Data on Multi-armored Allogeneic MUC1-CAR T-cells Targeting Triple-Negative Breast Cancer at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
Published: 2023-10-31 (Crawled : 20:00) - globenewswire.com
CLLS | $2.47 0.41% 0.4% 15K |

Health Technology

| 154.64% | O: 179.38% H: 10.33% C: -2.58%
pre-clinical breast cancer immunotherapy meeting

---

Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
Published: 2023-10-31 (Crawled : 13:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.7M |

Health Technology

| 218.92% | O: -1.35% H: 5.21% C: 4.66%
pre-clinical tumor immunotherapy meeting

---

Cellectis to Present Pre-Clinical Data on Multi-armored Allogeneic MUC1-CAR T-cells Targeting Triple-Negative Breast Cancer at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
Published: 2023-09-27 (Crawled : 20:00) - globenewswire.com
CLLS | $2.47 0.41% 0.4% 15K |

Health Technology

| 54.38% | O: -1.25% H: 2.22% C: 0.0%
pre-clinical breast cancer immunotherapy meeting

---

Iovance Biotherapeutics to Present Clinical and Pre-Clinical Data for Tumor Infiltrating Lymphocyte (TIL) Therapies at Society for Tumor Immunotherapy of Cancer’s (SITC) 38th Annual Meeting
Published: 2023-09-27 (Crawled : 20:00) - globenewswire.com
IOVA M | $11.72 -0.68% -0.68% 3.7M |

Health Technology

| 162.22% | O: -0.44% H: 2.01% C: 1.79%
pre-clinical tumor immunotherapy meeting

---

Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on its Anti-aVb8 Monoclonal Antibody (CRB-601) at the 2023 SITC Annual Meeting
Published: 2023-09-27 (Crawled : 13:00) - prnewswire.com
CRBP | $36.53 -1.7% -1.91% 130K |

Health Technology

| 539.5% | O: 0.0% H: 6.07% C: -1.24%
crb-601 pre-clinical antibody pharmaceuticals meeting

---

Corbus Pharmaceuticals to Present Latest Pre-Clinical Data on CRB-601 avβ8 Blocking Antibody at the New York Academy of Sciences' Frontiers in Cancer Immunotherapy Meeting
Published: 2023-05-01 (Crawled : 13:20) - biospace.com/
CRBP | $36.53 -1.7% -1.91% 130K |

Health Technology

| 368.34% | O: 0.0% H: 3.64% C: -3.42%
crb-601 pre-clinical antibody cancer pharmaceuticals immunotherapy meeting

---

Compugen to Present Data on its Lead Pre-Clinical Asset COM503 in an Oral Presentation at the 20th CIMT Annual Meeting
Published: 2023-04-26 (Crawled : 11:00) - prnewswire.com
CGEN | $2.03 3.57% 3.45% 450K |

Health Technology

| 281.67% | O: 0.0% H: 1.67% C: -1.67%
com503 pre-clinical presentation meeting

---

Tonix Pharmaceuticals Announces Presentations of Pre-Clinical Data on TNX-1700 in Syngeneic Models of Colorectal and Gastric Cancer at the American Association for Cancer Research Annual Meeting 2023
Published: 2023-04-19 (Crawled : 13:00) - globenewswire.com
TNXP | $0.157 -1.51% -2.91% 1.4M |

Health Technology

| -95.01% | O: 1.39% H: 1.42% C: -1.34%
tnx-1700 pre-clinical association cancer pharmaceuticals research meeting

---

Corbus Pharmaceuticals Presents Latest Pre-Clinical Data on CRB-601 at the 2023 American Association for Cancer Research Annual Meeting
Published: 2023-04-17 (Crawled : 14:00) - biospace.com/
CRBP | $36.53 -1.7% -1.91% 130K |

Health Technology

| 328.78% | O: -1.25% H: 10.56% C: 10.45%
crb-601 pre-clinical association cancer pharmaceuticals research meeting

---

BridGene Biosciences to Present Pre-Clinical Data of BGI-9004 at the AACR Annual Meeting 2023
Published: 2023-04-17 (Crawled : 12:00) - prnewswire.com
FNCTF | News | $11.0354 -0.83% -20.84% 0 |

Communications

| Email alert Add to watchlist
bgi-9004 pre-clinical meeting

---

Ocular Therapeutix™ To Present Pre-Clinical and Clinical Data at the 2023 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Published: 2023-04-14 (Crawled : 20:00) - ocutx.gcs-web.com
OCUL | News | $5.86 -22.69% -29.35% 6.1M |

Health Technology

| Email alert Add to watchlist
pre-clinical association ocular research meeting

---

Avacta to Present Pre-Clinical Data on AVA3996 at the American Association for Cancer Research Annual Meeting
Published: 2023-03-27 (Crawled : 12:00) - biospace.com/
FNCTF | News | $11.0354 -0.83% -20.84% 0 |

Communications

| Email alert Add to watchlist
ava3996 pre-clinical association cancer research meeting

---

Jazz Pharmaceuticals to Present Data at 2023 AACR Annual Meeting Showcasing New Zepzelca® (lurbinectedin) Data and Expanded Oncology Pre-Clinical and Clinical Pipeline
Published: 2023-03-15 (Crawled : 12:20) - biospace.com/
JAZZ | $109.27 2.03% 2.01% 560K |

Health Technology

| -20.83% | O: -1.52% H: 1.7% C: 1.25%
BGNE | $131.96 0.08% 0.06% 110K |

Health Technology

| -42.05% | O: 3.85% H: 0.32% C: -1.78%
zepzelca pharmaceuticals pre-clinical meeting pipeline

---

Corbus Pharmaceuticals to Present Pre-Clinical Data for CRB-601 at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
Published: 2022-10-14 (Crawled : 12:20) - prnewswire.com
CRBP | $36.53 -1.7% -1.91% 130K |

Health Technology

| 933.69% | O: -1.96% H: 3.08% C: -7.69%
crb-601 pharmaceuticals immunotherapy pre-clinical meeting cancer

---

Cellectis to Present Pre-Clinical Data on TALEN®-edited Smart CAR T-cells Supporting Improved Solid Tumor Targeting at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
Published: 2022-10-05 (Crawled : 23:00) - biospace.com/
CLLS | $2.47 0.41% 0.4% 15K |

Health Technology

| 2.49% | O: -3.73% H: 7.32% C: 2.59%
talen immunotherapy pre-clinical smart meeting

---

Nuvalent to Present New NVL-655 Preclinical Data and ARROS-1 Trial in Progress Poster for NVL-520 at IASLC 2022 World Conference on Lung Cancer Annual Meeting
Published: 2022-07-13 (Crawled : 11:00) - prnewswire.com
NUVL | $63.06 -1.85% -2.03% 620K |

| 280.85% | O: -2.19% H: 10.67% C: 7.76%
nvl-655 nvl-520 conference preclinical meeting trial cancer pre-clinical

---

Rubius Therapeutics Presents Updated Data from its Type 1 Diabetes Preclinical Program at the Federation of Clinical Immunology Societies (FOCIS) 2022 Annual Meeting
Published: 2022-06-22 (Crawled : 14:00) - biospace.com/
RUBY | $0.057 -99.3% 760K |

Health Technology

| -94.37% | O: -11.73% H: 21.91% C: 14.92%
preclinical immunology meeting program therapeutics diabetes pre-clinical

---

SQZ Biotechnologies Presents Celiac Disease Tolerizing Antigen Carrier Preclinical Data at 2022 Federation of Clinical Immunology Societies (FOCIS) Annual Meeting
Published: 2022-06-21 (Crawled : 11:00) - biospace.com/
SQZ | $0.435 0.0% 30M |

Health Technology

| -85.88% | O: 2.92% H: 0.0% C: 0.0%
disease preclinical sqz immunology meeting pre-clinical

---

Sana Biotechnology Announces Multiple Preclinical Data Presentations to Showcase Its Hypoimmune Platform, Including in Type 1 Diabetes, at the Upcoming ISSCR 2022 Annual Meeting
Published: 2022-06-13 (Crawled : 22:00) - biospace.com/
SANA | $7.73 -6.42% -6.72% 1.9M |

| 77.63% | O: -5.38% H: 2.9% C: -5.45%
preclinical pre-clinical

---

Gainers vs Losers

59%

41%

Top 10 Gainers

AGBA | News | $1.03 157.5% 57.94% 120M |

Finance

ZCMD | $1.45 5.84% 52.1% 2.3M |

Commercial Services

INVO | $1.52 100.0% 51.13% 5M |

Health Technology

ISPC | $0.421 97.65% 49.53% 37M |

Professional, Scientific, and T...

WLGS | News | $0.5 45.65% 470K |

OST | $0.509 23.81% 45.26% 90K |

GDHG | $0.263 21.76% 40.66% 3.1M |

XPON | News | $3.15 63.21% 37.74% 16M |

TIRX | $0.8 65.02% 30.74% 58M |

BNTC | News | $6.82 42.08% 30.64% 3.5M |

Health Technology

---

Your saved searches

---